AIM
ARK Investment Management’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122M | Buy |
13,017,876
+6,861
| +0.1% | +$64.4K | 0.9% | 32 |
|
|
2025
Q1 | $92.5M | Buy |
13,011,015
+474,629
| +4% | +$3.37M | 0.93% | 30 |
|
|
2024
Q4 | $146M | Buy |
12,536,386
+280,946
| +2% | +$3.28M | 1.22% | 25 |
|
|
2024
Q3 | $252M | Buy |
12,255,440
+659,651
| +6% | +$13.6M | 2.3% | 11 |
|
|
2024
Q2 | $260M | Buy |
11,595,789
+606,507
| +6% | +$13.6M | 2.3% | 12 |
|
|
2024
Q1 | $302M | Sell |
10,989,282
-423,167
| -4% | -$11.6M | 2.09% | 13 |
|
|
2023
Q4 | $348M | Buy |
11,412,449
+1,463,820
| +15% | +$44.6M | 2.06% | 16 |
|
|
2023
Q3 | $315M | Buy |
9,948,629
+422,698
| +4% | +$13.4M | 2.41% | 17 |
|
|
2023
Q2 | $388M | Sell |
9,525,931
-311,235
| -3% | -$12.7M | 2.57% | 14 |
|
|
2023
Q1 | $367M | Buy |
9,837,166
+416,384
| +4% | +$15.5M | 2.52% | 14 |
|
|
2022
Q4 | $329M | Sell |
9,420,782
-236,270
| -2% | -$8.24M | 2.85% | 10 |
|
|
2022
Q3 | $540M | Buy |
9,657,052
+142,472
| +1% | +$7.97M | 3.77% | 6 |
|
|
2022
Q2 | $439M | Buy |
9,514,580
+533,551
| +6% | +$24.6M | 2.6% | 12 |
|
|
2022
Q1 | $653M | Buy |
8,981,029
+1,064,147
| +13% | +$77.3M | 2.72% | 12 |
|
|
2021
Q4 | $936M | Buy |
7,916,882
+1,173,326
| +17% | +$139M | 2.83% | 13 |
|
|
2021
Q3 | $905M | Sell |
6,743,556
-940,885
| -12% | -$126M | 2.17% | 14 |
|
|
2021
Q2 | $1.24B | Sell |
7,684,441
-1,927,470
| -20% | -$312M | 2.32% | 13 |
|
|
2021
Q1 | $771M | Sell |
9,611,911
-1,579,759
| -14% | -$127M | 1.53% | 15 |
|
|
2020
Q4 | $609M | Sell |
11,191,670
-213,082
| -2% | -$11.6M | 1.62% | 16 |
|
|
2020
Q3 | $227M | Buy |
11,404,752
+1,373
| +0% | +$27.3K | 1.34% | 25 |
|
|
2020
Q2 | $240M | Buy |
11,403,379
+1,164,093
| +11% | +$24.5M | 2.58% | 11 |
|
|
2020
Q1 | $125M | Buy |
10,239,286
+1,497,854
| +17% | +$18.3M | 3.12% | 9 |
|
|
2019
Q4 | $128M | Buy |
8,741,432
+270,856
| +3% | +$3.97M | 3.23% | 8 |
|
|
2019
Q3 | $113M | Buy |
8,470,576
+227,411
| +3% | +$3.04M | 2.47% | 14 |
|
|
2019
Q2 | $135M | Buy |
8,243,165
+261,967
| +3% | +$4.29M | 3.4% | 8 |
|
|
2019
Q1 | $136M | Buy |
7,981,198
+1,179,246
| +17% | +$20.1M | 3.89% | 9 |
|
|
2018
Q4 | $92.8M | Buy |
6,801,952
+1,048,162
| +18% | +$14.3M | 3.77% | 9 |
|
|
2018
Q3 | $165M | Buy |
5,753,790
+1,240,206
| +27% | +$35.5M | 4.98% | 2 |
|
|
2018
Q2 | $123M | Buy |
4,513,584
+910,608
| +25% | +$24.9M | 4.53% | 3 |
|
|
2018
Q1 | $76M | Buy |
3,602,976
+2,227,827
| +162% | +$47M | 3.77% | 5 |
|
|
2017
Q4 | $26.4M | Buy |
1,375,149
+1,002,671
| +269% | +$19.3M | 2.11% | 14 |
|
|
2017
Q3 | $9.26M | Buy |
372,478
+197,668
| +113% | +$4.91M | 1.13% | 35 |
|
|
2017
Q2 | $2.8M | Buy |
174,810
+94,960
| +119% | +$1.52M | 0.54% | 45 |
|
|
2017
Q1 | $1.13M | Buy |
79,850
+53,306
| +201% | +$751K | 0.32% | 47 |
|
|
2016
Q4 | $348K | Buy |
+26,544
| New | +$348K | 0.13% | 64 |
|